Table 1.
Apical Supernatant
|
Cell Lysate
|
|||
---|---|---|---|---|
MAb (150μg/mL) | Blue Cell # | % Virus Reductionb | Blue Cell # | % Virus Reductionb |
pIgR+ Cells | ||||
Control | 136 ± 16 | 1797 ± 194 | ||
RT-IgA | 84 ± 23 | 38c | 1143 ± 200 | 36c |
RT-IgG | 133 ± 20 | 3 | 1851 ± 197 | 0 |
Gag-IgA | 81 ± 18 | 40c | 1176 ± 128 | 35c |
Gag-IgG | 129 ± 17 | 5 | 1777 ± 164 | 1 |
Irrelevant IgA | 131 ± 27 | 4 | 1871 ± 357 | 0 |
pIgR− Cells | ||||
Control | 152 ± 12 | 1943 ± 134 | ||
RT-IgA | 155 ± 33 | 0 | 1872 ± 127 | 4 |
Gag-IgA | 159 ± 32 | 0 | 1933 ± 137 | 1 |
Polarized monolayers of pIgR+ or pIgR− Vero C1008 cells were transfected with HIV proviral DNA for 4 h and then exposed to MAbs basolaterally for 18 h. HIV levels in apical supernatants and cell lysates 30 h post transfection were determined by infecting target HeLa cells (“blue cell” assay). Data are means from eight data points ± SEM pooled from four experiments.
Compared to the no antibody control.
Result significantly different (p<0.005) from the no antibody control according to a two-tailed t-test.